International reference pricing in the context of U.S. drug policy Richard G. Frank, Rena M. Conti, and Jonathan Gruber Tuesday, July 26, 2022
The economic case for federal investment in COVID-19 vaccines and therapeutics remains strong Susan Athey, Rena M. Conti, Matthew Fiedler, Richard G. Frank, and Jonathan Gruber Friday, April 1, 2022
Regulating drug prices while increasing innovation Rena M. Conti, Richard G. Frank, and Jonathan Gruber Wednesday, December 1, 2021
Addressing the trade-off between lower drug prices and incentives for pharmaceutical innovation Rena M. Conti, Richard G. Frank, and Jonathan Gruber Monday, November 15, 2021
Restructuring Cost Sharing and Supplemental Insurance for Medicare Jonathan Gruber Tuesday, February 26, 2013
T Taking Massachusetts National: An Incremental Approach to Universal Health Insurance Jonathan Gruber Thursday, July 24, 2008
2007 Jul 17 Past Event Who’s Got the Cure? Four Options for Achieving Universal Coverage 9:00 AM - 12:30 PM EDT Washington, DC
E Encouraging Homeownership Through the Tax Code Jonathan Gruber, Seth Stephens-Davidowitz, and William G. Gale Monday, June 18, 2007
I Improving Opportunities and Incentives for Saving by Middle- and Low-Income Households Jonathan Gruber, Peter R. Orszag, and William G. Gale Saturday, April 1, 2006
D Does the Social Security Earnings Test Affect Labor Supply and Benefits Receipt? Jonathan Gruber and Peter R. Orszag Monday, November 26, 2001
